Primary Premature Ejaculation Genetics
Identification Des Bases moléculaires de l'éjaculation prématurée Primaire
2 other identifiers
interventional
70
1 country
3
Brief Summary
The main objective of our study is to identify the first genetic etiology of primary Premature Ejaculation (PE). We will test and evaluate the existence of genetic determinism conferring susceptibility to a life-long syndrome (primary premature ejaculation) in some patients. To this end, we plan to establish a collection of biological samples and a database of patients with this extreme syndrome, which we will analyze by Genome Wide analysis. This will lead to improvements in the biological understanding, the "knowledge" of physicians of the disease, and should improve the patients' quality of life. Not all PE cases have the same physiopathology and treatment efficiency, which depend on the specific mechanism involved in the clinical context. Our work will make it possible to develop new therapeutic approaches suitable for a large proportion of individuals presenting PE. This integrative approach combining researchers, patients and ethics committees will facilitate profound reflection, promoting the creation of suitable structures capable of receiving patients for appropriate consultations. This unique study of PE should also favor industrial partnerships.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2014
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 2, 2014
CompletedFirst Posted
Study publicly available on registry
April 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2020
CompletedMarch 14, 2025
January 1, 2025
5.9 years
April 2, 2014
March 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of subjects with genetic mutations of susceptibility to primary PE
We will perform WES (Whole Exome Sequencing) to identify shared defective genes in 20 patients. In case of genetic uniformity and of a genetically homogeneous recruitment, we hope to highlight such a gene in several individuals. As primary PE are very rare, this group should have defective genes at much higher frequencies than in the control population (NCBI, 1000 genome and housing-genome). This will allow us to identify genetic mutations of susceptibility to primary PE.
4 years
Study Arms (1)
Men over 18 years of age with primary Premature Ejaculation
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patients (index cases ) Prospective and retrospective cases
- Man aged over 18 years
- signing the informed consent
- Presenting primary PE
- have an affiliation to a social security system
- Related
- Male or female over 18 years
- be related to the index case
- signing the informed consent
- have an affiliation to a social security system
- Patients ( index case ) :
- Be aged under 18
- have known genetic variations that predispose or can promote psychological disorders that can lead to PE ( eg: Kallman 's Syndrome , micropenis , testicular dysgenesis , Klinfelter syndrome, Leydig cell hypoplasia )
- have had psycho- social and psycho- traumatic factors in childhood
- Inability to receive clear information on the protocol
- +13 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Polyclinique de Blois
La Chaussée-Saint-Victor, 41260, France
Hôpital Saint Joseph
Marseille, 13285, France
Hôpital Necker
Paris, 75015, France
Related Publications (1)
Porto R, Giuliano F. [Premature ejaculation]. Prog Urol. 2013 Jul;23(9):647-56. doi: 10.1016/j.purol.2013.01.005. Epub 2013 Mar 1. French.
PMID: 23830259BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Alcaïs, MD
Hôpital Necker
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2014
First Posted
April 9, 2014
Study Start
April 1, 2014
Primary Completion
February 11, 2020
Study Completion
February 11, 2020
Last Updated
March 14, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share